Gynecologic cancer outcomes in the elderly poor: A population-based study

Cancer

Volumn 121, Issue 20, 2015, Pages 3591-3599

  Doll, Kemi M ^a,b,c   Meng, Ke ^c   Basch, Ethan M ^c   Gehrig, Paola A ^a,c   Brewster, Wendy R ^a,c   Meyer, Anne Marie ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

aged; female genital neoplasms; Medicaid; Medicare; outcomes research

Indexed keywords

AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; COHORT ANALYSIS; FEMALE; FEMALE GENITAL TRACT CANCER; HUMAN; MAJOR CLINICAL STUDY; MEDICARE; OUTCOME ASSESSMENT; OVARY CANCER; POPULATION RESEARCH; POVERTY; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER; UTERUS CANCER; VAGINA CANCER; VULVA CANCER; DUAL ELIGIBILITY (HEALTH INSURANCE); ECONOMICS; GENITAL NEOPLASMS, FEMALE; MEDICAL CARE; MULTIVARIATE ANALYSIS; NORTH CAROLINA; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DUAL MEDICAID MEDICARE ELIGIBILITY; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MEDICAL ASSISTANCE; MULTIVARIATE ANALYSIS; NORTH CAROLINA; POVERTY; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84943584765     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29541     Document Type: Article

References (53)

1. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA,. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009; 27: 2758-2765.
2. Wright JD, Lewin SN, Barrena Medel NI, et al., Morbidity and mortality of surgery for endometrial cancer in the oldest old. Am J Obstet Gynecol. 2011; 205: 66.e1-e8.
3. Sharma C, Deutsch I, Horowitz DP, et al., Patterns of care and treatment outcomes for elderly women with cervical cancer. Cancer. 2012; 118: 3618-3626.
4. Wright JD, Lewin SN, Deutsch I, et al., Defining the limits of radical cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2011; 123: 467-473.
5. Garg G, Yee C, Schwartz K, Mutch DG, Morris RT, Powell MA,. Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis. Gynecol Oncol. 2014; 133: 242-249.
6. Howlander N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2012. Bethesda, MD: National Cancer Institute; 2015.
7. Truong PT, Kader HA, Lacy B, et al., The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer. Am J Clin Oncol. 2005; 28: 157-164.
8. Wright JD, Lewin SN, Barrena Medel NI, et al., Endometrial cancer in the oldest old: tumor characteristics, patterns of care, and outcome. Gynecol Oncol. 2011; 122: 69-74.
9. Ahmed A, Zamba G, DeGeest K, Lynch CF,. The impact of surgery on survival of elderly women with endometrial cancer in the SEER program from 1992-2002. Gynecol Oncol. 2008; 111: 35-40.
10. Mahdi H, Lockhart D, Maurer KA,. Impact of age on 30-day mortality and morbidity in patients undergoing surgery for endometrial cancer. Gynecol Oncol. 2015; 137: 106-111.
11. Suh DH, Kang S, Lim MC, et al., Management of the elderly patient with gynecologic cancer: report of the 2011 workshop in geriatric gynecologic oncology. Int J Gynecol Cancer. 2012; 22: 161-169.
12. Sabatier R, Calderon B Jr, Lambaudie E, et al., Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study. Int J Gynecol Cancer. 2015; 25: 815-822.
13. Mold JW, Fryer GE, Thomas CH,. Who are the uninsured elderly in the United States? J Am Geriatr Soc. 2004; 52: 601-606.
14. Department of Health and Human Services. Medicare. Available at: http://www.medicare.gov. Accessed April 30, 2014.
15. North Carolina Department of Health and Human Services. A consumer's guide to Medicare savings programs within North Carolina Medicaid. Available at: http://www.ncdhhs.gov. Accessed June 15, 2015.
16. Department of Health and Human Services. 2008 HHS poverty guidelines. Fed Regist. 2008; 73: 3971-3972.
17. Phelan JC, Link BG, Tehranifar P,. Social conditions as fundamental causes of health inequalities: theory, evidence, and policy implications. J Health Soc Behav. 2010; 51 (suppl): S28-S40.
18. Tehranifar P, Neugut AI, Phelan JC, et al., Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2701-2708.
19. Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH,. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol. 2014; 133: 353-361.
20. Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ 2nd, Chen VW,. Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol. 1996; 88: 919-926.
21. Randall TC, Armstrong K,. Differences in treatment and outcome between African-American and white women with endometrial cancer. J Clin Oncol. 2003; 21: 4200-4206.
22. Bristow RE, Zahurak ML, Ibeanu OA,. Racial disparities in ovarian cancer surgical care: a population-based analysis. Gynecol Oncol. 2011; 121: 364-368.
23. Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB,. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health. 2004; 94: 2104-2111.
24. del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E,. Ethnic differences in patterns of care of stage 1A(1) and stage 1A(2) cervical cancer: a SEER database study. Gynecol Oncol. 1999; 75: 113-117.
25. Farley JH, Hines JF, Taylor RR, et al., Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer. 2001; 91: 869-873.
26. Winter WE 3rd, Maxwell GL, Tian C, et al,; Gynecologic Oncology Group Study. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007; 25: 3621-3627.
27. Bristow RE, Powell MA, Al-Hammadi N, et al., Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst. 2013; 105: 823-832.
28. Simard EP, Naishadham D, Saslow D, Jemal A,. Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009. Gynecol Oncol. 2012; 127: 611-615.
29. Fedewa SA, Lerro C, Chase D, Ward EM,. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database. Gynecol Oncol. 2011; 122: 63-68.
30. University of North Carolina At Chapel Hill Lineberger Comprehensive Cancer Center. ICISS data resources. Available at: iciss.unc.edu/data.php. Accessed January 1, 2013.
31. Koroukian SM, Dahman B, Copeland G, Bradley CJ,. The utility of the state buy-in variable in the Medicare denominator file to identify dually eligible Medicare-Medicaid beneficiaries: a validation study. Health Serv Res. 2010; 45: 265-282.
32. O'Donnell B, Schneider K, Roozeboom M,. Options for Determining Which Medicare Beneficiaries Are Dually Eligible: Technical Guidance. 2012. Available at: www.resdac.org. Accessed June 15, 2015.
33. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
34. Goff BA, Matthews BJ, Larson EH, et al., Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer. 2007; 109: 2031-2042.
35. Bristow RE, Palis BE, Chi DS, Cliby WA,. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol. 2010; 118: 262-267.
36. Chan JK, Urban R, Cheung MK, et al., Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer. 2006; 95: 1314-1320.
37. Chan JK, Cheung MK, Husain A, et al., Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol. 2006; 108 (3 pt 1): 521-528.
38. Baldwin LA, Huang B, Miller RW, et al., Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol. 2012; 120: 612-618.
39. Rauh-Hain JA, Clemmer J, Clark RM, et al., Management and outcomes for elderly women with vulvar cancer over time. BJOG. 2014; 121: 719-727; discussion 727.
40. Earle CC, Schrag D, Neville BA, et al., Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006; 98: 172-180.
41. Chan JK, Sherman AE, Kapp DS, et al., Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011; 29: 832-838.
42. Gordon HS, Street RL Jr, Sharf BF, Souchek J,. Racial differences in doctors' information-giving and patients' participation. Cancer. 2006; 107: 1313-1320.
43. Gordon HS, Street RL Jr, Sharf BF, Kelly PA, Souchek J,. Racial differences in trust and lung cancer patients' perceptions of physician communication. J Clin Oncol. 2006; 24: 904-909.
44. Radley DC, McCarthy D, Lippa JA, Hayes SL, Schoen C,. Higher: Results From a Scorecard on State Health System Performance, 2014. New York: The Commonwealth Fund; 2014.
45. Hershman DL, Wright JD,. Comparative effectiveness research in oncology methodology: observational data. J Clin Oncol. 2012; 30: 4215-4222.
46. Glynn RJ, Schneeweiss S, Sturmer T,. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol. 2006; 98: 253-259.
47. Hernan MA, Alonso A, Logan R, et al., Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 2008; 19: 766-779.
48. Meyer AM, Wheeler SB, Weinberger M, Chen RC, Carpenter WR,. An overview of methods for comparative effectiveness research. Semin Radiat Oncol. 2014; 24: 5-13.
49. Sturmer T, Rothman KJ, Avorn J, Glynn RJ,. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution-a simulation study. Am J Epidemiol. 2010; 172: 843-854.
50. Walker AM,. Confounding by indication. Epidemiology. 1996; 7: 335-336.
51. Newhouse JP, McClellan M,. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health. 1998; 19: 17-34.
52. Brookhart MA, Rassen JA, Schneeweiss S,. Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf. 2010; 19: 537-554.
53. Chan JK, Gomez SL, O'Malley CD, Perkins CI, Clarke CA,. Validity of cancer registry Medicaid status against enrollment files: implications for population-based studies of cancer outcomes. Med Care. 2006; 44: 952-955.